Patients and Methods
Abbreviations and Acronyms:ASP (Autonomic Symptom Profile), COMPASS (Composite Autonomic Symptom Score)
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms.Neurology. 1999; 52: 523-528
- Quality of life in patients with postural tachycardia syndrome.Mayo Clin Proc. 2002; 77: 531-537
- Correlates of functional disability in patients with postural tachycardia syndrome: preliminary cross-sectional findings.Health Psychol. 2003; 22: 643-648
- Depressive symptoms and life satisfaction in patients with multiple system atrophy.Mov Disord. 2005; 20: 951-957
- Autonomic symptoms and diabetic neuropathy: a population-based study.Diabetes Care. 2004; 27: 2942-2947
- Health-related quality of life in multiple system atrophy.Mov Disord. 2006; 21: 809-815
- Autonomic dysfunction in dementia with Lewy bodies.Neurology. 2004; 62: 1804-1809
- Syncope: approach to management.in: Low P.A. Benarroch E.E. Clinical Autonomic Disorders. 3rd ed. Lippincott Williams & Wilkins, Philadelphia2008: 493-514
- Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.J Urol. 1994; 151: 54-61
- Medications that may contribute to sexual disorders: a guide to assessment and treatment in family practice.J Fam Pract. 1997; 44: 33-43
- Scale Development: Theory and Applications.Sage Publications, Newbury Park, CA1991
- The measurement of observer agreement for categorical data.Biometrics. 1977; 33: 159-174
- Factor Analysis.2nd ed. Lawrence Erlbaum Associates, Hillsdale, NJ1983
- The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale.Clin Auton Res. 2012; 22: 79-90
- Evaluation of orthostatic hypotension: relationship of a new self-report instrument to laboratory-based measures.Mayo Clin Proc. 2005; 80: 330-334
Grant Support: This work was supported in part by grants from the National Institutes of Health (NIH) ( NS 32352 , Autonomic Disorders Program Project; NS 44233 , Pathogenesis and Diagnosis of Multiple System Atrophy; U54 NS065736 , Autonomic Rare Disease Clinical Consortium; and K23NS075141 ) and the Mayo Clinic Center for Translational Science Activities ( UL1 RR24150 ). The Autonomic Diseases Consortium is a part of the NIH Rare Diseases Clinical Research Network. Funding and/or programmatic support for this project was provided by grant U54 NS065736 from the National Institute of Neurological Diseases and Stroke and the NIH Office of Rare Diseases Research .